Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00510432|
Recruitment Status : Unknown
Verified August 2009 by Johann Wolfgang Goethe University Hospital.
Recruitment status was: Recruiting
First Posted : August 2, 2007
Last Update Posted : August 19, 2009
An increased number of patients with heparin-induced skin lesions is reported in the literature. Heparin-induced skin lesions may result from either occlusion of cutaneous vessels in patients suffering from autoimmune HIT or from a type IV allergic reaction (delayed type hypersensitivity (DTH) response). However, the incidence and nature of heparin-induced skin lesions has not been determined in a prospective investigation.
To address this open issue is the goal of this ongoing, so far monocenter, clinical investigation.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Inzidenz Und Art Heparin-induzierter Hautveränderungen|
|Study Start Date :||April 2007|
|Estimated Study Completion Date :||January 2009|
s.c. anticoagulant therapy
All patients with s.c. anticoagulant therapy (UFH, LMWH, heparinoids, fondaparinux)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00510432
|Contact: Ralf J Ludwig, MD||+49-69-6301- ext firstname.lastname@example.org|
|Contact: Wolf-Henning Boehncke, Professor||+49-69-6301- ext email@example.com|
|Department of Dermatology - Clinic of the Johann Wolfgang Goethe University||Recruiting|
|Frankfurt am Main, Hessen, Germany, 60590|
|Contact: Ralf J Ludwig, MD +49-69-6301- ext 6162 firstname.lastname@example.org|
|Contact: Marc Schindewolf, MD +49-69-6301- ext 5444 email@example.com|
|Principal Investigator: Ralf J Ludwig, MD|
|Sub-Investigator: Marc Schindewolf, MD|
|Sub-Investigator: Svantje Schwaner, MD|
|Sub-Investigator: Edelgard Lindhoff-Last, PD|
|Sub-Investigator: Wolf-Henning Boehncke, Prof|
|Principal Investigator:||Ralf J Ludwig, MD||Department of Dermatology - Clinic of the Johann Wolfgang Goethe University|